Purchase this report

Breakthroughs in Non-Alcoholic Steatohepatitis Management

Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development

Published	Pages	Publisher	Report code
Mar 2019	46	Frost & Sullivan	ASDR-485060

Published: Mar 2019 - Pages : 46 - Publisher : Frost & Sullivan - Report code : ASDR-485060

Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market Forecast 2021-2028 Published: January, 2021 - Pages: 218
Non-Alcoholic Steatohepatitis (NASH) Market Forecast to 2028 - COVID-19 Impact and Global Analysis Published: April, 2022 - Pages: 178
Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 20... Published: March, 2022 - Pages: 807
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 Published: March, 2021 - Pages: 1254
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market - 2022-2029 Published: October, 2022 - Pages: 170
Global Non-Alcoholic Steatohepatitis (NASH) Market: Size and Trends with Impact of COVID-19 and Forecast up to 2027 Published: January, 2023 - Pages: 130
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020 Published: July, 2020 - Pages: 1101
Global Non-alcoholic Steatohepatitis Biomarkers Market Forecast, 2018-2023 Published: January, 2019 - Pages:
Non-Alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Obeticholic Acid, Lani... Published: August, 2022 - Pages: 110
NASH Biomarkers (Non alcoholic Steatohepatitis) Market Value forecast, New Business Opportunities and Companies: Outlook... Published: September, 2020 - Pages: 150